According to a previous study, ALT and AST levels were increased in serum by 61.7% and 32.2% in HFD-induced NAFLD mice, and apoptosis was upregulated in liver tissue in both mice and human patients [60]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.